Since 2014
Sardegna
Farmeconomia
View Archive Info| Field | Value | |
| Title |
Sardegna
|
|
| Creator |
Cavallo, Maria Caterina
Cipriani, Filippo Gerzeli, Simone Demarteau, Nadia Marocco, Alessia Bamfi, Francesco |
|
| Subject |
Pharmacoeconomics; Health economics
Sardinia; HPV vaccination; Economic & clinical impact |
|
| Description |
In Sardinia region 45,5% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 38 cases of cervicocarcinoma and 15 related deaths and thus results to be cost-effective (15.347 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 41 cancer cases and 18 deaths could be prevented, with a very similar cost-effectiveness ratio. In Sardinia region, the net cost for woman vaccinated is 148 € for the single cohort and 152 € for the multiple cohort. |
|
| Publisher |
SEEd Medical Publishers
|
|
| Date |
2008-09-15
|
|
| Type |
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion — |
|
| Format |
application/pdf
|
|
| Identifier |
https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1019
10.7175/fe.v9i1S.1019 |
|
| Source |
Farmeconomia. Health economics and therapeutic pathways; Vol 9, No 1S (2008); 91-93
2240-256X |
|
| Language |
eng
|
|
| Relation |
https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1019/1237
|
|
| Rights |
Copyright (c) 2008 Farmeconomia. Health economics and therapeutic pathways
http://creativecommons.org/licenses/by-nc/4.0 |
|